Anti-CD79b (clone ch10D10)-Mc-MMAF ADC

  • Check with publisher
  • Published date: September 25, 2020
    • United States

This ADC product is comprised of an anti-CD79b monoclonal antibody (clone ch10D10) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. https://www.creative-biolabs.com/adc/target-cd79b-17.htm

Result 0 votes
Jerry Carter
1 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-CD79b (clone huMA79b.v28)-Mc-VC-PABC-MMAE ADC

    Anti-CD79b (clone huMA79b.v28)-Mc-VC-PABC-MMAE ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated...

  • Anti-CD79b (clone huMA79b.v28)-BMPEO-DM1 ADC

    Anti-CD79b (clone huMA79b.v28)-BMPEO-DM1 ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a BMPEO linker to DM1. The DM1 is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocy...

  • Anti-CD79b (clone huMA79b.v28)-Mc-MMAF ADC

    Anti-CD79b (clone huMA79b.v28)-Mc-MMAF ADC

    Drug Development (United States ) September 25, 2020 Check with publisher

    This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocyt...